Sendero Wealth Management LLC raised its position in Humana Inc. (NYSE:HUM - Free Report) by 28.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,440 shares of the insurance provider's stock after buying an additional 978 shares during the period. Sendero Wealth Management LLC's holdings in Humana were worth $1,085,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC grew its position in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares during the last quarter. Garde Capital Inc. acquired a new position in Humana in the first quarter worth $36,000. Zions Bancorporation National Association UT bought a new stake in shares of Humana during the first quarter worth $37,000. Ransom Advisory Ltd acquired a new stake in shares of Humana in the first quarter valued at $66,000. Finally, Rakuten Securities Inc. increased its stake in shares of Humana by 50.0% in the first quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider's stock valued at $79,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on HUM shares. Morgan Stanley decreased their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Bank of America upped their target price on shares of Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research report on Tuesday, September 2nd. Barclays lowered their price target on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating for the company in a report on Friday. Sanford C. Bernstein upped their price objective on Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Finally, Weiss Ratings reiterated a "sell (d+)" rating on shares of Humana in a research report on Saturday, September 27th. Seven equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $291.21.
Read Our Latest Report on HUM
Humana Stock Performance
Shares of Humana stock opened at $284.00 on Monday. The firm has a fifty day moving average of $274.76 and a two-hundred day moving average of $257.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The stock has a market capitalization of $34.16 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 1.67 and a beta of 0.42. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.
Humana Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana's dividend payout ratio is 27.17%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.